Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters
IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics, creating a high-resolution immune dataset to advance AI-driven biomedical research and disease prediction. The post Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters appeared first on GEN - Genetic Engineering and Biotechnology News .
London-based IMU Biosciences has joined forces with the UK Biobank to create the most comprehensive and detailed map of the human immune system. By utilizing IMU's HD Immunology platform, Waters Corporation's flow cytometry and multiomic instrumentation, and Ultima Genomics' UG200 Sequencing Platform, the collaboration aims to generate over 100 million immune data points from tens of thousands of blood samples.
The resulting dataset will add a new layer to UK Biobank's existing de-identified genomic, imaging, clinical, and lifestyle data, allowing researchers to study immune variation's relationship to disease risk, progression, treatment response, and long-term health outcomes.
Brief written by urgent.news from GEN Biotechnology's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
